National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings, 27420-27421 [2020-09927]
Download as PDF
27420
Federal Register / Vol. 85, No. 90 / Friday, May 8, 2020 / Notices
To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
The Teaching Health Center Graduate
Medical Education Program
Reconciliation Tool OMB No. 0915–
0342—Extension.
Abstract: The Teaching Health Center
Graduate Medical Education (THCGME)
program, authorized by Section 340H of
the Public Health Service Act, was
established by Section 5508 of Public
Law (Pub. L.) 111–148. The Bipartisan
Budget Act of 2018 (Pub. L. 115–123)
provided continued funding for the
THCGME Program for fiscal years 2018
and 2019 and the Further Continuing
Appropriations Act, 2020, and the
Coronavirus Aid, Relief, and Economic
Security (CARES) Act extends funding
for Fiscal Year (FY) 2020 for the first
two months of FY 2021 (until November
30, 2020).
THCGME program awards payment
for both direct and indirect expenses to
support training for primary care
residents in community-based
ambulatory patient care settings. Direct
medical expense payments are designed
to compensate eligible teaching health
centers for those expenses directly
associated with resident training, while
indirect medical expense payments are
intended to compensate for the
additional costs of training residents in
such programs.
A 60-day notice published in the
Federal Register on January 22, 2020,
Vol. 85, No. 14; pp. 3696–97. There
were no public comments.
Need and Proposed Use of the
Information: THCGME program
payments are prospective payments,
and the statute provides for a
reconciliation process, through which
overpayments may be recouped and
underpayments may be adjusted at the
end of the fiscal year. This data
collection instrument will gather
information relating to the number of
resident full-time equivalents in
Teaching Health Center training
programs in order to reconcile payments
for both direct and indirect expenses.
Likely Respondents: The likely
responders to the THCGME
Reconciliation Tool are THCGME
program award recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
THCGME Reconciliation Tool ..............................................
58
1
58
2
116
Total ..............................................................................
58
........................
58
........................
116
Maria G. Button,
Director, Executive Secretariat.
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2020–09906 Filed 5–7–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
VerDate Sep<11>2014
17:46 May 07, 2020
Jkt 250001
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Institutional Training Mechanism Review
Committee.
Date: June 4–5, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL1
6705 Rockledge, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6705 Rockledge Drive,
Bethesda, MD 20892, 301–827–7911,
lindsay.garvin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Dated: May 5, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09920 Filed 5–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
E:\FR\FM\08MYN1.SGM
08MYN1
Federal Register / Vol. 85, No. 90 / Friday, May 8, 2020 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Cooperative Agreement for Clinical Trials in
Communication Disorders (U01).
Date: June 2, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
(301) 496–8683, el6r@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Clinical Research Center Review.
Date: June 4, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Ste 8300, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351 Bethesda, MD
20892 (301) 496–8683 katherine.shim@
nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Clinical Trial Review.
Date: June 23, 2020.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.
Ste 8300, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, (301) 496–8683, katherine.shim@
nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Application Review.
Date: July 7, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.
Ste 8300, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
VerDate Sep<11>2014
17:46 May 07, 2020
Jkt 250001
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
(301) 496–8683, el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: May 5, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09927 Filed 5–7–20; 8:45 am]
BILLING CODE 4140–01–P
27421
Lung, and Blood Institute, 6705 Rockledge
Drive, Room 207–P, Bethesda, MD 20892–
7924, (301) 827–7942, lismerin@
nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 5, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–09919 Filed 5–7–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Emerging Investigator Award (EIA)
(R35 Clinical Trial Optional).
Date: June 18, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, 6705 Rockledge Drive, Room
207–Q, Bethesda, MD 20892–7924
(Telephone Conference Call).
Contact Person: Tony L. Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 207–Q,
Bethesda, MD 20892–7924, (301) 827–7913,
creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trials SEP.
Date: June 22, 2020.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: May 21, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: Ongoing and new activities at the
Frederick National Laboratory for Cancer
Research.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Caron A. Lyman, Ph.D.,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W126,
Bethesda, MD 20892–9750, 240–276–6348,
lymanc@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/fac/fac.htm,
where an agenda, instructions for access, and
E:\FR\FM\08MYN1.SGM
08MYN1
Agencies
[Federal Register Volume 85, Number 90 (Friday, May 8, 2020)]
[Notices]
[Pages 27420-27421]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09927]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial
[[Page 27421]]
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; NIDCD Cooperative
Agreement for Clinical Trials in Communication Disorders (U01).
Date: June 2, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room 8339, MSC 9670, Bethesda,
MD 20892-8401, (301) 496-8683, [email protected].
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; NIDCD Clinical
Research Center Review.
Date: June 4, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd., Ste 8300, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Katherine Shim, Ph.D., Scientific Review
Officer, Division of Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351 Bethesda, MD 20892 (301) 496-8683
[email protected].
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; NIDCD Clinical Trial
Review.
Date: June 23, 2020.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd. Ste 8300, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Katherine Shim, Ph.D., Scientific Review
Officer, Division of Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD 20892, (301) 496-8683,
[email protected].
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; Hearing and Balance
Application Review.
Date: July 7, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd. Ste 8300, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room 8339, MSC 9670, Bethesda,
MD 20892-8401, (301) 496-8683, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: May 5, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-09927 Filed 5-7-20; 8:45 am]
BILLING CODE 4140-01-P